Dataset from A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/00006886
下载链接
链接失效反馈官方服务：
资源简介：
The primary purpose of this study is to evaluate the overall efficacy of aripiprazole
intramuscular (IM) depot as acute treatment in subjects with schizophrenia.
The secondary purpose is to evaluate the safety and tolerability of aripiprazole IM depot
administered every 4 weeks for 12 weeks to adult subjects with schizophrenia.
创建时间：
2026-04-10
